Prognostic Relevance of Pretherapeutic Gamma-Glutamyltransferase in Patients with Primary Metastatic Breast Cancer
Open Access
- 27 April 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (4), e0125317
- https://doi.org/10.1371/journal.pone.0125317
Abstract
Gamma-glutamyltransferase (GGT) is a known marker for apoptotic balance and cell detoxification. Recently, an association of baseline GGT levels and breast cancer incidence, tumor progression and chemotherapy resistance was shown. The purpose of this study was to evaluate the association of pre-therapeutic GGT levels, clinical-pathological parameters and survival in patients with primary metastatic breast cancer (PMBC). In this multicenter analysis, pre-therapeutic GGT levels and clinical-pathological parameters of 114 patients diagnosed with PMBC between 1996 and 2012 were evaluated. The association between GGT levels and clinical-pathological parameters were analysed. Patients were stratified into four GGT risk-groups (GGT < 18.00 U/L: normal low, 18.00 to 35.99 U/L: normal high, 36.00 to 71.99 U/L: elevated and ≥ 72.00 U/L: highly elevated) and survival analyses were performed. Patients in the high risk GGT group had a poorer overall survival, when compared to the low risk group with five-year overall survival rates of 39.5% and 53.7% (p = 0.04), respectively. Patients with larger breast tumors had a trend towards higher GGT levels (p = 0.053). Pre-therapeutic GGT levels were not associated with indicators of aggressive tumor biology such as HER2-status, triple negative histology, or poorly differentiated cancers. Pre-therapeutic GGT serum level might serve as a novel prognostic factor for overall-survival in patients with PMBC.Keywords
This publication has 26 references indexed in Scilit:
- Gamma‐glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancerColorectal Disease, 2013
- Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals Of Oncology, 2012
- Gamma-glutamyl transferase: risk and prognosis of cancerBritish Journal of Cancer, 2012
- Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trialBritish Journal of Cancer, 2012
- γ-Glutamyl transferase and breast cancer riskBritish Journal of Cancer, 2010
- Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literatureBreast Cancer Research and Treatment, 2009
- Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality RiskArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Modulation of cell growth and cisplatin sensitivity by membrane γ-glutamyltransferase in melanoma cellsEuropean Journal of Cancer, 2006
- Serum γ‐glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factorsDiabetic Medicine, 2005
- The Role of Gamma-Glutamyl Transpeptidase in the Preoperative Metastatic Evaluation of Renal Cell CarcinomaJournal of Urology, 1997